Oliver Wiseman participates at the American Urological Association Annual Congress
6th July 2016
In May 2016, in San Diego, Oliver Wiseman, CUP partner, participated in the AUA, the largest urological congress in the world. As the National Lead for publication of the surgeon specific outcomes of PCNL (percutaneous nephrolithotomy) he presented results of the analyses undertaken with colleagues on a number of aspects of this work. He also gave a plenary talk at the joint meeting of the British Association of Urological Surgeons / Australian and News Zealand Urological Association and British Journal of Urology International as to how publication of these outcomes might lead to improved outcomes for patients. Further work which was presented included analysis for a UK research group (NUKE: Network of UK Endourologists) looking at the costs of flexible ureteroscopy in the UK, now that there is a single use flexible ureteroscope available on the market. Finally he chaired a symposium which looked more into the innovation behind, costs of, and reasons that single use ureteroscopes have been developed.
A full list of the abstracts and podium presentations is below:
Sunday, May 8, 2016 1:00 PM-3:00 PM
SDCC:
Stone Disease: Surgical Therapy V
Funding: Boston Scientific
MP51-03: Comparison of a new single-use digital flexible ureteroscope (Lithovue TM) to a non-disposable fibre-optic flexible ureteroscope in a live porcine model
Oliver Wiseman*, Cambridge, United Kingdom, Francis Keeley, Bristol, United Kingdom, Olivier Traxer, Paris, France, Guido Giusti, Milan, Italy, Michael Lipkin, Glenn Preminger, Durham, NC
Saturday, May 7, 2016 1:00 PM-3:00 PM
SDCC:
Stone Disease: Surgical Therapy III
Funding: none
MP33-10: PCNL in the United Kingdom: Trends in 5000 cases from BAUS PCNL Registry
William Finch*, Norwich, United Kingdom, Robert Calvert, Liverpool, United Kingdom, Sarah Fowler, London, United Kingdom, James Armitage, Cambridge, United Kingdom, Jonathan Glass, John Withington, London, United Kingdom, Oliver Wiseman, Cambridge, United Kingdom, Stuart Irving, Neil Burgess, Norwich, United Kingdom
Saturday, May 7, 2016 1:00 PM-3:00 PM
SDCC:
Surgical Technology & Simulation: Instrumentation & Technology II
Funding: None
PD19-07: Flexible Ureteroscopy durability in the hands of UK surgeons: a snapshot
William Finch*, Norwich, United Kingdom, Nick Rukin, Wolverhampton, United Kingdom, Jake Patterson, Sheffield, United Kingdom, Sunil Kumar, Reading, United Kingdom, Oliver Wiseman, Cambridge, United Kingdom
Saturday, May 7, 2016 10:30 AM-12:30 PM
SDCC:
Stone Disease: Surgical Therapy II
Funding: None
PD18-04: PCNL access by Urologist or Radiologist: An analysis of the BAUS PCNL Registry
James Armitage*, Cambridge, United Kingdom, Sarah Fowler, London, United Kingdom, William Finch, Neil Burgess, Stuart Irving, Norwich, United Kingdom, John Withington, Jonathan Glass, London, United Kingdom, Oliver Wiseman, Cambridge, United Kingdom
Saturday, May 7, 2016 3:30 PM-5:30 PM
SDCC:
Surgical Technology & Simulation: Instrumentation & Technology III
Funding: None
MP34-04: Urologists’ Views on Live Surgical Broadcasts and Better than Live Surgery
Yih Chyn Phan*, Redhil, United Kingdom, Oliver Wiseman, Cambridge, United Kingdom, Philip James, Redhil, United Kingdom, Ralph Clayman, Orange, CA, Arthur Smith, New Hyde Park, NY, Abhay Rane, Redhil, United Kingdom
Tuesday, May 10, 2016 10:30 AM-12:30 PM
SDCC:
Stone Disease: Epidemiology & Evaluation II
Funding: None
PD47-01: Assessing the Volume-Outcome Relationship for PCNL in 2014- Analysis using UK National Registry Data of over 2000 cases
John Withington*, London, United Kingdom, William Finch, Norwich, United Kingdom, Sarah Fowler, London, United Kingdom, James Armitage, Cambridge, United Kingdom, Jonathan Glass, London, United Kingdom, Stuart Irving, Neil Burgess, Norwich, United Kingdom, Kay Thomas, London, United Kingdom, Oliver Wiseman, Cambridge, United Kingdom